E-ISSN: 1309-0380
Low-dose methotrexate administration in the management of cervical pregnancy
PDF
Cite
Share
Request
Original Investigation
VOLUME: 10 ISSUE: 2
P: 99-103
June 2009

Low-dose methotrexate administration in the management of cervical pregnancy

J Turk Ger Gynecol Assoc 2009;10(2):99-103
Christine E. Reissmann 1
Tamme W. Goecke 1
Matthias W. Beckmann 1
Ralf L. Schild 2
Peter Oppelt 3
1. Department Of Gynecology And Obstetrics, Erlangen, Germany
2. Department Of Obstetrics, Hannover, Germany
3. Department Of Gynecology, General Hospital Of Linz, Linz, Austria
No information available.
No information available
Received Date: 31.01.2009
Accepted Date: 30.03.2009
PDF
Cite
Share
Request

ABSTRACT

OBJECTIVE:

Cervical pregnancy is a rare form of ectopic pregnancy. There is the risk of hysterectomy when this type of ectopic pregnancy is managed with surgery. An established form of conservative treatment is the administration of methotrexate (MTX). We demonstrate the effectiveness of a low-dose MTX regimen.

MATERIALS-METHODS:

Case analysis of cervical pregnancies at a tertiary referral center at an University Hospital. Six patients presented with cervical or isthmocervical pregnancies. Low-dose of MTX was administered intravenous. Secondary surgical intervention was carried out when needed. The main outcome measures were to preserve childbearing capacity using conservative treatment partly followed by curettage for cervical pregnancy.

RESULTS:

Six patients received conservative treatment with MTX in a low-dose regimen. During the course of conservative treatment with MTX, three patients underwent curettage. One of these patients also received an intra-amniotic administration in addition to systemic administration of MTX.

CONCLUSIONS:

Systemic low-dose methotrexate treatment is an effective form of primary treatment, with a low rate of side effects.

Keywords:
cervical pregnancy, methotrexate, low-dose regime